Two drugs ordered out of the market

By Don Asoka Wijewardena

Two kinds of drugs called ‘Cicloshporine capsule ’ (100mg given to kidney transplant patients to prevent rejection of transplanted kidneys) marketed by Indian Alvita Pharma company and ‘promethazine’ injection phial marketed by the same company had been temporarily suspended until further notice as these two kinds of medicine were found to be substandard, the Health Ministry said.

Cosmetic Devices and Drug Regulatory Authority Director Dr. H. Beneragama, contacted for comment, said that on his request Director General of Health Services Dr. Palitha Maheepala had officially had asked the Indian Alvita Pharma Company’s local agent to stop supplying the two drugs until further notice.

He pointed out that two drugs had failed quality tests. Samples thereof had been sent to a quality assurance laboratory in Australia and found to be of low quality, he said.

animated gif
Processing Request
Please Wait...